Follitropin Alfa is an ovulation stimulator which was approved by the US Food and Drug Administration on 29th September 1997.

Follitropin Alfa Injection is indicated to treat infertility in men and women. It induces healthy ovaries to produce egg in women and enhances mature sperm production in men.

Follitropin Alfa is available as multidose syringe injection in the doses 75IU, 150IU, 225IU, 300IU, 900IU and 1200IU. Your healthcare provider will administer the injection through subcutaneous route.

The common side effects that are likely to occur while you are on the treatment with Follitropin Alfa Injection are ovarian cyst, pelvic pain, gas, headache, nausea, stomach pain, bleeding between periods in women and skin problems, injection site pain, tiredness, breast enlargement and seborrhoea in men. If you experience any allergic reactions like swelling of face, shortness of breath, redness or itching after taking this medicine, report to your healthcare provider immediately.

Follitropin Alfa Injection is not recommended for people who are hypersensitive to Follitropin Alfa or its ingredients. Before starting this treatment, the healthcare provider will conduct ultrasound scan of the ovaries for women and semen testing for men. Your healthcare provider will monitor your blood pressure, heart function, liver and kidney parameters during this treatment to prevent complications. Tell your healthcare provider if you have been diagnosed with asthma, thrombosis, ovarian cyst, twisted ovaries, polycystic ovarian disease, or have undergone abdominal surgery in the past. Seek immediate medical attention if you experience sudden bleeding, severe stomach pain, unusual bleeding, decreased urine output.

Follitropin Alfa is not recommended for use during pregnancy as it has the tendency to cause fetal harm. Tell your physician before starting this treatment if you are pregnant or planning to get pregnant. It is not known if Follitropin Alfa passes into the breast milk. If you are a breastfeeding mother, your health care provider will suggest whether to discontinue breastfeeding or discontinue this treatment based on your condition.

Eat a well-balanced diet and consume plenty of water to maintain hydration. Tell your healthcare provider if you are taking any prescription medication, over-the counter medicine, vitamin or herbal supplements.

1. EMD Serono Inc., [Revised on Dec 2020] [Accessed on 14th Oct 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020378s045,s067,s075lbl.pdf
2. Roger K. Long, Hakan Cakmak, Hypothalamic & Pituitary Hormones, Lange's Basic & Clinical Pharmacology, 14th Edition, 2018, 667-686.

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.